Tianjin Chase Sun Pharmaceutical Co.,Ltd announced earnings results for the nine months ended September 30, 2020. For the nine months, the company announced sales was CNY 4,708.513 million compared to CNY 3,602.061 million a year ago. Operating income was CNY 643.360 million compared to CNY 620.473 million a year ago. Net income was CNY 599.127 million compared to CNY 516.260 million a year ago. Basic earnings per share from continuing operations was CNY 0.2 compared to CNY 0.17 a year ago.